{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:49:11Z","timestamp":1760906951796,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4470,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.fertnstert.2008.11.030","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T05:45:01Z","timestamp":1233985501000},"page":"1179-1184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"93","author":[{"given":"Devrim","family":"Ertunc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekrem C.","family":"Tok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysun","family":"Savas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilay","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saffet","family":"Dilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.11.030_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib3","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.fertnstert.2006.05.046","article-title":"Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome","volume":"86","author":"van Wely","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib4","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/humrep\/16.11.2258","article-title":"Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist","volume":"16","author":"Ragni","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib5","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajog.2004.06.072","article-title":"A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with ganirelix during superovulation\/IUI therapy","volume":"191","author":"Williams","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/humrep\/dei386","article-title":"Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial","volume":"21","author":"Lambalk","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/humrep\/del416","article-title":"Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial","volume":"22","author":"Crosignani","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/humrep\/del337","article-title":"GnRH antagonist\u2013induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial","volume":"22","author":"Allegra","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.fertnstert.2007.03.035","article-title":"Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles","volume":"89","author":"G\u00f3mez-Palomares","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/humrep\/deh602","article-title":"Timing ovulation for intrauterine insemination with a GnRH antagonist","volume":"20","author":"G\u00f3mez-Palomares","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.fertnstert.2005.08.040","article-title":"Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends","volume":"85","author":"Checa","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10815-005-9019-8","article-title":"Gn-RH antagonists in intrauterine insemination: the weekend-free protocol","volume":"23","author":"Matorras","year":"2006","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review","volume":"14","author":"Al-Inany","year":"2007","journal-title":"Reprod Biomed Online"},{"issue":"5 Suppl","key":"10.1016\/j.fertnstert.2008.11.030_bib15","first-page":"S178","article-title":"Ovarian hyperstimulation syndrome","volume":"86","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-7547-5-12","article-title":"Methods for analyzing cost effectiveness data from cluster randomized trials","volume":"5","author":"Bachmann","year":"2007","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/humupd\/dml001","article-title":"GnRH antagonists in ovarian stimulation for IVF","volume":"12","author":"Tarlatzis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.fertnstert.2007.06.064","article-title":"Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis","volume":"90","author":"Kosmas","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0015-0282(00)01499-0","article-title":"Management of women with polycystic ovary syndrome who experienced premature luteinization during clomiphene citrate treatment","volume":"74","author":"Lidor","year":"2000","journal-title":"Fertil Steril"},{"issue":"Suppl 3","key":"10.1016\/j.fertnstert.2008.11.030_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000191298","article-title":"Effect of luteinizing hormone\u2013releasing hormone analogs on the rat ovarian follicle development","volume":"48","author":"Yano","year":"1997","journal-title":"Horm Res"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib21","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/0002-9378(95)90490-5","article-title":"Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa lutein cells","volume":"172","author":"Minaretzis","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/humrep\/14.4.885","article-title":"Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?","volume":"14","author":"Lin","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/humrep\/16.8.1663","article-title":"Utero-ovarian blood flow characteristics of pituitary desensitization","volume":"16","author":"Dada","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/ob.1996.v175.a73865","article-title":"Blood flow changes in the ovarian and uterine arteries during the normal menstrual cycle","volume":"175","author":"Tan","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0015-0282(01)01918-5","article-title":"Increased progesterone\/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization\u2013embryo transfer cycles with a long gonadotropin-releasing hormone agonist","volume":"76","author":"Younis","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.fertnstert.2005.09.021","article-title":"Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists","volume":"85","author":"Ragni","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)58017-0","article-title":"Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization","volume":"65","author":"Buyalos","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.030_bib28","unstructured":"Segal S, Glatstein I, McShane P, Hotamisligil S, Ezcurra D, Carson R. Premature luteinization and in vitro fertilization outcome in gonadotropin\/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome. Fertil Steril. In press."}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208046517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208046517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:41:55Z","timestamp":1758008515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208046517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0015028208046517"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.11.030","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}